Albandar, H. J., Fuqua, J., Albandar, J. M., Safi, S., Merrill, S. A., & Ma, P. C. (2021). Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not? Cancers (Basel).
シカゴスタイル引用形Albandar, Heidar J., Jacob Fuqua, Jasim M. Albandar, Salahuddin Safi, Samuel A. Merrill, , Patrick C. Ma. "Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?" Cancers (Basel) 2021.
MLA引用形式Albandar, Heidar J., et al. "Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?" Cancers (Basel) 2021.
警告: この引用は必ずしも正確ではありません.